Metaxalone
- Product NDC
- 68788-7499
- 11-digit product format
- 687887499
- Labeler code
- 68788
- Product ID
- 68788-7499_f9b312f6-9bd2-43c9-b6ba-01e8cd61e1d3
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Metaxalone
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Preferred Pharmaceuticals, Inc.
- Application
- ANDA208774
- Marketing category
- ANDA
- Marketing start
- 2018-09-24
- Marketing end
- 0000-00-00
- Substance
- METAXALONE
- Active strength
- 800 mg/1
- Pharmacologic classes
- Centrally-mediated Muscle Relaxation [PE]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 68788-7499 | METAXALONE TABLET [PREFERRED PHARMACEUTICALS, INC.] | 5 | Legacy NDC | 20240704_3f3a4ca6-999e-4d1d-8a3e-796bdc4ef2fa.zip |
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 68788-7499-0 | 68788749900 | 15 TABLET in 1 BOTTLE (68788-7499-0) | 15 tablet | 2019-12-27 | 0000-00-00 | No | No | Current |
| 68788-7499-1 | 68788749901 | 100 TABLET in 1 BOTTLE (68788-7499-1) | 100 tablet | 2019-12-27 | 0000-00-00 | No | No | Current |
| 68788-7499-2 | 68788749902 | 20 TABLET in 1 BOTTLE (68788-7499-2) | 20 tablet | 2019-12-27 | 0000-00-00 | No | No | Current |
| 68788-7499-3 | 68788749903 | 30 TABLET in 1 BOTTLE (68788-7499-3) | 30 tablet | 2019-12-27 | 0000-00-00 | No | No | Current |
| 68788-7499-6 | 68788749906 | 60 TABLET in 1 BOTTLE (68788-7499-6) | 60 tablet | 2019-12-27 | 0000-00-00 | No | No | Current |
| 68788-7499-9 | 68788749909 | 90 TABLET in 1 BOTTLE (68788-7499-9) | 90 tablet | 2019-12-27 | 0000-00-00 | No | No | Current |